FDA Removes Warnings on Hormone Replacement Therapy for Women
TL;DR
The U.S. Department of Health and Human Services and the FDA are removing broad black box warnings from hormone replacement therapy (HRT) products for menopause, based on new scientific evidence showing benefits and reduced risks, aiming to empower women with better treatment options and improve access to affordable HRT medications.
Topics:top-newshealth#black-box-warnings#fda#health#hormone-replacement-therapy#menopause#womens-health
- HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy U.S. Department of Health and Human Services (HHS) (.gov)
- F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause The New York Times
- Hormone replacement therapy will no longer carry a warning label, FDA says NBC News
- Opinion | Marty Makary: The FDA Liberates Women’s Hormone Replacement Therapy The Wall Street Journal
- WATCH: RFK Jr. says FDA will remove long-standing warning from hormone-based menopause drugs PBS
Want the full story? Read the original reporting
Read on U.S. Department of Health and Human Services (HHS) (.gov)